200 related articles for article (PubMed ID: 14516784)
1. The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation.
Weger S; Hammer E; Engstler M
Exp Cell Res; 2003 Oct; 290(1):13-27. PubMed ID: 14516784
[TBL] [Abstract][Full Text] [Related]
2. The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML.
Engelhardt OG; Boutell C; Orr A; Ullrich E; Haller O; Everett RD
Exp Cell Res; 2003 Feb; 283(1):36-50. PubMed ID: 12565818
[TBL] [Abstract][Full Text] [Related]
3. Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.
Weger S; Hammer E; Heilbronn R
FEBS Lett; 2005 Sep; 579(22):5007-12. PubMed ID: 16122737
[TBL] [Abstract][Full Text] [Related]
4. The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies.
Rasheed ZA; Saleem A; Ravee Y; Pandolfi PP; Rubin EH
Exp Cell Res; 2002 Jul; 277(2):152-60. PubMed ID: 12083797
[TBL] [Abstract][Full Text] [Related]
5. P300 transcriptional repression is mediated by SUMO modification.
Girdwood D; Bumpass D; Vaughan OA; Thain A; Anderson LA; Snowden AW; Garcia-Wilson E; Perkins ND; Hay RT
Mol Cell; 2003 Apr; 11(4):1043-54. PubMed ID: 12718889
[TBL] [Abstract][Full Text] [Related]
6. The E3 ligase Topors induces the accumulation of polysumoylated forms of DNA topoisomerase I in vitro and in vivo.
Hammer E; Heilbronn R; Weger S
FEBS Lett; 2007 Nov; 581(28):5418-24. PubMed ID: 17976381
[TBL] [Abstract][Full Text] [Related]
7. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies.
Engelhardt OG; Ullrich E; Kochs G; Haller O
Exp Cell Res; 2001 Dec; 271(2):286-95. PubMed ID: 11716541
[TBL] [Abstract][Full Text] [Related]
8. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
Kunapuli P; Kasyapa CS; Chin SF; Caldas C; Cowell JK
Exp Cell Res; 2006 Nov; 312(19):3739-51. PubMed ID: 17027752
[TBL] [Abstract][Full Text] [Related]
9. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53.
Rajendra R; Malegaonkar D; Pungaliya P; Marshall H; Rasheed Z; Brownell J; Liu LF; Lutzker S; Saleem A; Rubin EH
J Biol Chem; 2004 Aug; 279(35):36440-4. PubMed ID: 15247280
[TBL] [Abstract][Full Text] [Related]
10. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo.
Antoine K; Prosperi MT; Ferbus D; Boule C; Goubin G
Mol Cell Biochem; 2005 Mar; 271(1-2):215-23. PubMed ID: 15881673
[TBL] [Abstract][Full Text] [Related]
11. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation.
Duprez E; Saurin AJ; Desterro JM; Lallemand-Breitenbach V; Howe K; Boddy MN; Solomon E; de Thé H; Hay RT; Freemont PS
J Cell Sci; 1999 Feb; 112 ( Pt 3)():381-93. PubMed ID: 9885291
[TBL] [Abstract][Full Text] [Related]
12. Topors, a p53 and topoisomerase I binding protein, interacts with the adeno-associated virus (AAV-2) Rep78/68 proteins and enhances AAV-2 gene expression.
Weger S; Hammer E; Heilbronn R
J Gen Virol; 2002 Mar; 83(Pt 3):511-516. PubMed ID: 11842245
[TBL] [Abstract][Full Text] [Related]
13. Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358.
Saitoh H; Pizzi MD; Wang J
J Biol Chem; 2002 Feb; 277(7):4755-63. PubMed ID: 11709548
[TBL] [Abstract][Full Text] [Related]
14. Noncovalent SUMO-1 binding activity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and colocalization with the promyelocytic leukemia protein.
Takahashi H; Hatakeyama S; Saitoh H; Nakayama KI
J Biol Chem; 2005 Feb; 280(7):5611-21. PubMed ID: 15569683
[TBL] [Abstract][Full Text] [Related]
15. Identification of phosphorylation sites of TOPORS and a role for serine 98 in the regulation of ubiquitin but not SUMO E3 ligase activity.
Park HJ; Zheng H; Kulkarni D; Kerrigan J; Pungaliya P; Saleem A; Rubin EH
Biochemistry; 2008 Dec; 47(52):13887-96. PubMed ID: 19053840
[TBL] [Abstract][Full Text] [Related]
16. Heat shock and Cd2+ exposure regulate PML and Daxx release from ND10 by independent mechanisms that modify the induction of heat-shock proteins 70 and 25 differently.
Nefkens I; Negorev DG; Ishov AM; Michaelson JS; Yeh ET; Tanguay RM; Müller WE; Maul GG
J Cell Sci; 2003 Feb; 116(Pt 3):513-24. PubMed ID: 12508112
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo.
Eloranta JJ; Hurst HC
J Biol Chem; 2002 Aug; 277(34):30798-804. PubMed ID: 12072434
[TBL] [Abstract][Full Text] [Related]
18. SUMO-1 modification of the Wilms' tumor suppressor WT1.
Smolen GA; Vassileva MT; Wells J; Matunis MJ; Haber DA
Cancer Res; 2004 Nov; 64(21):7846-51. PubMed ID: 15520190
[TBL] [Abstract][Full Text] [Related]
19. Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein.
Haluska P; Saleem A; Rasheed Z; Ahmed F; Su EW; Liu LF; Rubin EH
Nucleic Acids Res; 1999 Jun; 27(12):2538-44. PubMed ID: 10352183
[TBL] [Abstract][Full Text] [Related]
20. A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions.
Liu ST; Chang YL; Wang WM; Chung MH; Lin WS; Chou WY; Huang SM
Int J Biochem Cell Biol; 2012 Mar; 44(3):547-55. PubMed ID: 22227369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
